Y-mAbs Therapeutics - Stock Price History | YMAB

Historical daily share price chart and data for Y-mAbs Therapeutics since 2021 adjusted for splits. The latest closing stock price for Y-mAbs Therapeutics as of September 24, 2021 is 28.70.
  • The all-time high Y-mAbs Therapeutics stock closing price was 54.26 on December 17, 2020.
  • The Y-mAbs Therapeutics 52-week high stock price is 55.22, which is 92.4% above the current share price.
  • The Y-mAbs Therapeutics 52-week low stock price is 24.77, which is 13.7% below the current share price.
  • The average Y-mAbs Therapeutics stock price for the last 52 weeks is 37.86.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Y-mAbs Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 38.3004 30.5000 54.2600 14.3900 49.5100 58.43%
2019 25.0583 18.2100 33.7800 18.2100 31.2500 53.64%
2018 23.1783 24.0000 28.9200 15.4100 20.3400 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.317B $0.021B
Y-mAbs Therapeutics Inc. is a biopharmaceutical company. It focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. The company's product pipeline consists of naxitamab and omburtamab which are in clinical stage. Y-mAbs Therapeutics Inc. is based in NEW YORK, USA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71